Clinical Trial Update: Non Inferiority Trial Investigating Surfactants Administered Via MIST [Phase 4]

View source ↗

Summary

Phase 4 non-inferiority trial evaluating surfactants delivered via minimally invasive surfactant therapy (MIST) for respiratory distress syndrome; currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Surfactant via MIST (unspecified)

Snippet

Sponsor: Endeavor Health | Conditions: Respiratory Distress Syndrome | Phase 4 | Status: RECRUITING